Duke University
Duke University
Durham, North Carolina, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab | Newly Diagnosed Glioblastoma | Recruiting | Phase 2 | 2026-09-17 | NCT06816927 | |
| Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-04-15 | NCT06126744 |